INVESTIGATION NOTICE: Kaskela Law LLC Announces Investigation of Melinta Therapeutics, Inc. on Behalf of Stockholders – MLNT

November 30, 2018

RADNOR, Pa., Nov. 30, 2018 (GLOBE NEWSWIRE) -- Kaskela Law LLC is investigating Melinta Therapeutics, Inc. (“Melinta” or the “Company”) (NASDAQ: MLNT) on behalf of stockholders.

The investigation seeks to determine whether members of Melinta’s board of directors breached their fiduciary duties to the Company and its stockholders in connection with recent corporate actions, and whether Melinta investors have been harmed as a result of such actions.

Melinta stockholders are encouraged to immediately contact Kaskela Law LLC (D. Seamus Kaskela, Esq.) at (888) 715 – 1740, or online at http://kaskelalaw.com/case/melinta-therapeutics-inc/, to discuss this investigation and their legal rights and options.

Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and other stockholder actions. For additional information about Kaskela Law LLC please visit www.kaskelalaw.com. This notice may constitute attorney advertising in certain jurisdictions.


KASKELA LAW LLCD. Seamus Kaskela, Esq.201 King of Prussia RoadSuite 650Radnor, PA 19087 (484) 258 – 1585(888) 715 – 1740 skaskela@kaskelalaw.comwww.kaskelalaw.com

Update hourly